0001484565-23-000001.txt : 20231004 0001484565-23-000001.hdr.sgml : 20231004 20231004103632 ACCESSION NUMBER: 0001484565-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231004 DATE AS OF CHANGE: 20231004 EFFECTIVENESS DATE: 20231004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC CENTRAL INDEX KEY: 0001484565 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-493753 FILM NUMBER: 231306827 BUSINESS ADDRESS: STREET 1: 203 REDWOOD SHORES PARKWAY STREET 2: SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-213-8444 MAIL ADDRESS: STREET 1: 203 REDWOOD SHORES PARKWAY STREET 2: SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Capnia, Inc. DATE OF NAME CHANGE: 20100219 D 1 primary_doc.xml X0708 D LIVE 0001484565 SOLENO THERAPEUTICS INC 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA CALIFORNIA 94065 650-213-8444 DELAWARE Capnia, Inc. Corporation true Anish Bhatnagar 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Executive Officer Director William Harris 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Director Andrew Sinclair 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Director Ernest Mario 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Director Birgitte Volck 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Director Gwen Melincoff 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Director Matthew Pauls 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Director James Mackaness 203 Redwood Shores Pkwy #500 Redwood City CA CALIFORNIA 94065 Executive Officer Biotechnology Decline to Disclose 06b false 2023-10-02 false true true true false 0 59988250 59988250 0 false 14 3599295 0 0 false SOLENO THERAPEUTICS INC /s/James Mackaness James Mackaness CFO 2023-10-04